Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Drugs in Dermatology : JDD|March 17, 2017
Dermatologists: Collaborating With Payers to Optimize Coverage PoliciesDavid A Amato, William N Malatestinic, Matthew C Palmgren, et al.
The Journal of Dermatological Treatment|July 8, 2021
Psoriasis treatment patterns and outcomes with ixekizumab in a real-world setting: results from a single US dermatology referral practiceCraig Leonardi, Rei Tao, Solmaz Setayeshgar, et al.
Journal of Psoriasis and Psoriatic Arthritis|September 20, 2024
Factors Associated With Treatment Escalation for Psoriasis: An Analysis of Electronic Health Records DataJamie L W Rhoads, William N Malatestinic, Russel Burge, et al.
The Journal of Dermatological Treatment|October 6, 2021
Inadequate response and treatment patterns in adults diagnosed with atopic dermatitis and treated with topical therapyMagdaliz Gorritz, Natalie N Boytsov, Orin M Goldblum, et al.
The Journal of Dermatological Treatment|March 23, 2021
The current treatment landscape in adult atopic dermatitis in the United States: results from a cross-sectional real-world studyNatalie N Boytsov, Magdaliz Gorritz, Xin Wang, et al.
Journal of Managed Care & Specialty Pharmacy|December 24, 2021
US health care utilization and costs in adult patients with atopic dermatitis by disease severityXin Wang, Natalie N Boytsov, Magdaliz Gorritz, et al.
Journal of Comparative Effectiveness Research|December 23, 2020
Understanding characteristics of patients newly initiating ixekizumab: findings from the Corrona Psoriasis RegistryJashin J Wu, Ryan W Harrison, Baojin Zhu, et al.
Dermatology and Therapy|July 11, 2023
Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support ProgramAlice B Gottlieb, Russel Burge, William N Malatestinic, et al.
Pageof 3